- Home
- KLTR vs ACHV Comparison
KLTR vs ACHV Comparison
Compare KLTR & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLTR
- ACHV
- Stock Information
- Founded
- KLTR 2006
- ACHV N/A
- Country
- KLTR United States
- ACHV Canada
- Employees
- KLTR N/A
- ACHV N/A
- Industry
- KLTR EDP Services
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- KLTR Technology
- ACHV Health Care
- Exchange
- KLTR Nasdaq
- ACHV Nasdaq
- Market Cap
- KLTR 177.3M
- ACHV 159.0M
- IPO Year
- KLTR 2021
- ACHV N/A
- Fundamental
- Price
- KLTR $1.36
- ACHV $4.60
- Analyst Decision
- KLTR Buy
- ACHV Strong Buy
- Analyst Count
- KLTR 3
- ACHV 3
- Target Price
- KLTR $2.67
- ACHV $14.00
- AVG Volume (30 Days)
- KLTR 114.2K
- ACHV 87.2K
- Earning Date
- KLTR 11-06-2024
- ACHV 11-07-2024
- Dividend Yield
- KLTR N/A
- ACHV N/A
- EPS Growth
- KLTR N/A
- ACHV N/A
- EPS
- KLTR N/A
- ACHV N/A
- Revenue
- KLTR $176,832,000.00
- ACHV N/A
- Revenue This Year
- KLTR $2.29
- ACHV N/A
- Revenue Next Year
- KLTR $2.32
- ACHV N/A
- P/E Ratio
- KLTR N/A
- ACHV N/A
- Revenue Growth
- KLTR 2.65
- ACHV N/A
- 52 Week Low
- KLTR $0.76
- ACHV $3.03
- 52 Week High
- KLTR $2.03
- ACHV $5.98
- Technical
- Relative Strength Index (RSI)
- KLTR 59.59
- ACHV 56.93
- Support Level
- KLTR $1.23
- ACHV $4.32
- Resistance Level
- KLTR $1.32
- ACHV $4.64
- Average True Range (ATR)
- KLTR 0.10
- ACHV 0.15
- MACD
- KLTR 0.02
- ACHV 0.04
- Stochastic Oscillator
- KLTR 100.00
- ACHV 92.59
About KLTR Kaltura Inc.
Kaltura Inc provides live and on-demand video SaaS solutions to thousands of organizations around the world, engaging hundreds of millions of viewers at home, at work, and at school. It also offers specialized industry solutions, including Learning Management System Video, Lecture Capture, and Virtual Classroom for educational institutions, as well as a TV Solution for media and telecom companies. It operates in two reporting segments which are Enterprise, Education, and Technology, and Media and Telecom. The majority of the revenue is derived from Enterprise, Education & Technology. The majority of the revenue is earned from the United States.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.